Meeting to be held in San Francisco on May 8 hosted by B. Riley.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IMMX:
- Immix Biopharma Awarded European Union Orphan Drug Designation for NXC-201 in Multiple Myeloma
- Immix Biopharma: EC grants orphan drug designation to NXC-201
- Immix Biopharma on Track to Dose NXC-201 Patients in United States
- Immix Biopharma says ‘on track’ to dose NXC-201 patients in U.S.
- Immix Biopharma Announces Late-Breaking NXC-201 Clinical Data Abstract Accepted for Oral Presentation at the 27th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT)